[Asia Economy Reporter Hwang Yoon-joo] UbioLogics announced on the 21st that it has signed a supply contract worth 13 billion KRW for oral cholera vaccine (Ubicol-Plus) with UNICEF. This amount corresponds to 45.66% of recent sales revenue. The contract period is from March 18, 2022, to May 25, 2022.
The company stated, "The contract amount is the KRW equivalent of $10,703,133.4 for a quantity of 5,772,300 doses of cholera vaccine."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
